Jump to content

Marcus Hacker

Edit links
From Wikipedia, the free encyclopedia

Marcus Hacker (* born on 19 Oktober 1969 in Eggenfelden, Germany) is a university professor and specialist in Nuclear medicine at the Medical University of Vienna (Vienna, Austria).[1][2]

Career

[edit]

After completing the medicine studies in Erlangen and Munich from 1989 to 1998 and completing his dissertation in 2002, Marcus Hacker was recognized as a specialist in nuclear medicine in 2004. From 2007, he worked as a senior physician for cardiovascular imaging and deputy head of PET/CT at the clinic of the LMU Munich, where he qualified as a professor in 2008 and was promoted to senior physician and deputy director in 2009[2]. In 2012, Marcus Hacker was appointed as an adjunct professor at the LMU Munich.[3][4][5][6] Since 2013, he has been a university professor for nuclear medicine and head of the Clinical Department of Nuclear Medicine at the Medical University of Vienna.[2][7][8]

Scientific Achievements

[edit]

Marcus Hacker is involved in the establishment of new individualized diagnostic and treatment procedures in nuclear medicine, particularly in cardiovascular, oncological and neuropsychiatric applications. The focus here is on in-vivo tissue characterization and the selection of suitable radiopharmaceuticals for patient-related individual risk assessment.In translational research, Marcus Hacker established new biomarkers for the identification of mechanistic relationships and for translation from cell or animal models to humans.[9][10]

As for October 2024, Marcus Hacker is author of 504 original scientific papers with 14,106 citations (excluding self-citations), and 28 book chapters[11][12][2][13]. The key areas of his academic interest are theranostics, PET and SPECT Hybrid Imaging, and Network- and Prevention Medicine[14][13].

Academic Awards

[edit]

Memberships

[edit]
  • 2022 - 2024     Speaker Medical Imaging Cluster, Medical University of Vienna, Austria;
  • 2017 - 2018     Chair of the Nuclear Cardiology Working Group (AG20) of the German Cardiac Society[2];
  • 2016 - 2018     Secretary and member of the executive board and chairman of the Cardiovascular Nuclear Medicine Working Group of the German Society for Nuclear Medicine[16][2];
  • 2018             Treasurer and Member of the Board of the Austrian Platform for Personalized Medicine;
  • 2016 President of the Austrian Society of Nuclear Medicine[16][25]and Molecular Imaging[2];
  • 2014 - 2017     Chair of the Cardiovascular Committee of the European Association of Nuclear Medicine[16][2] (Vienna, Austria);
  • 2014 Member of the Scientific Committee at the Germany Multiple CME Sessions at the Annual Congresses of the European Association of Nuclear Medicine (Hannover, Germany)[2];
  • 2013               Head of the Research Group for Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine[2];
  • 2013                Member of the Board of Directors of the Austrian Society of Nuclear Medicine and Molecular Imaging[16];
  • 2013                Sub-Chair of the Cardiovascular Committee at the Annual Congress of the Society of Nuclear Medicine in Vancouver, Canada[2];
  • 2013                 Voted Member of the Board of Directors of the German Society of Nuclear Medicine[16][2];
  • 2012                 Member of the European Council of Nuclear Cardiology[2];
  • 2012                 Member of the Cardiovascular Committee of the European Association of Nuclear Medicine[16];
  • 2010                 Member of the Scientific Committee at the Annual Congresses of the German Society of Nuclear Medicine Medicine and the Society of Nuclear Medicine[2];
  • 2010                 Member of the Research Group for Nuclear Cardiological Diagnostics of the German Society of Cardiology[16];
  • 2010                 Member of the Research Group for Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine[16].
[edit]

Bibliographic References

[edit]
  1. ^ "Marcus Hacker als Beirat beim Spezialistennetzwerk PRIMO MEDICO" (in German). Retrieved 2016-11-28.
  2. ^ a b c d e f g h i j k l m n o p "ORCID". orcid.org. Retrieved 2024-11-19.
  3. ^ "Lebenslauf Marcus Hacker" (PDF). OERG (Österreichische Röntgengesellschaft, Gesellschaft für Medizinische Radiologie und Nuklearmedizin). Archived from the original (PDF) on 2018-04-26. Retrieved 2024-11-25.
  4. ^ "Marcus Hacker" (in German). Retrieved 2016-12-06.
  5. ^ "Univ. Prof. Dr. med. Marcus Hacker". 530d6bed5756. Retrieved 2024-11-11.
  6. ^ HealthManagement.org. "Radiology Management, ICU Management, Healthcare IT, Cardiology Management, Executive Management". healthmanagement.org. Retrieved 2024-11-19.
  7. ^ "Neuer Leiter der Klinischen Abteilung für Nuklearmedizin" (in German). Retrieved 2016-12-08.
  8. ^ Vienna, Medical University of. "[In German:] Marcus Hacker erhält Professur für Nuklearmedizin". Medical University of Vienna. Retrieved 2024-11-11.
  9. ^ "Nuclearmedizin Wien" (in German). Retrieved 2016-12-12.
  10. ^ "Neuer Leiter Marcus Hacker" (in German). Retrieved 2016-12-12.
  11. ^ "Marcus Hacker". scholar.google.com. Retrieved 2024-10-21.
  12. ^ "Hacker M - Search Results - PubMed". PubMed. Retrieved 2024-10-21.
  13. ^ a b "MediFind". www.medifind.com. Retrieved 2024-11-19.
  14. ^ "Marcus Hacker - Klinik und Poliklinik für Nuklearmedizin, Klinikum der Ludwig-Maximilians-Universität München | 人才画像 - AMiner". www.aminer.cn. Retrieved 2024-11-19.
  15. ^ Hacker, Marcus; Jakobs, Tobias; Matthiesen, Florian; Vollmar, Christian; Nikolaou, Konstantin; Becker, Christoph; Knez, Andreas; Pfluger, Thomas; Reiser, Maximilian; Hahn, Klaus; Tiling, Reinhold (2005). "Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences". Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 46 (8): 1294–1300. ISSN 0161-5505. PMID 16085585.
  16. ^ a b c d e f g h i j k l "Meet Biograph Vision Quadra PET/CT experts". www.siemens-healthineers.com. Retrieved 2024-11-11.
  17. ^ Hacker, Marcus; Jakobs, Tobias; Hack, Nicolas; Nikolaou, Konstantin; Becker, Christoph; von Ziegler, Franz; Knez, Andreas; König, Andreas; Klauss, Volker; Reiser, Maximilian; Hahn, Klaus; Tiling, Reinhold (2007-01-01). "Sixty-four slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina". European Journal of Nuclear Medicine and Molecular Imaging. 34 (1): 4–10. doi:10.1007/s00259-006-0207-2. ISSN 1619-7089.
  18. ^ Rominger, Axel; Saam, Tobias; Wolpers, Sarah; Cyran, Clemens C.; Schmidt, Michael; Foerster, Stefan; Nikolaou, Konstantin; Reiser, Maximilian F.; Bartenstein, Peter; Hacker, Marcus (2009). "18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease". Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 50 (10): 1611–1620. doi:10.2967/jnumed.109.065151. ISSN 1535-5667. PMID 19759117.
  19. ^ "More articles from Cardiovascular Council Young Investigator Award Symposium | Journal of Nuclear Medicine". jnm.snmjournals.org. Retrieved 2024-11-19.
  20. ^ Uebleis, Christopher; Ulbrich, Michael; Tegtmeyer, Roland; Schuessler, Franziska; Haserueck, Nadine; Siebermair, Johannes; Becker, Christoph; Nekolla, Stephan; Cumming, Paul; Bartenstein, Peter; Kääb, Stefan; Hacker, Marcus (2011). "Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results". Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 52 (1): 67–71. doi:10.2967/jnumed.110.078709. ISSN 1535-5667. PMID 21149479.
  21. ^ a b Leister, Autor Timo (2017-02-07). "Univ.-Prof. Dr. med. Marcus Hacker – Mitgliedschaft im Netzwerk bestätigt". PRIMO MEDICO Blog (in German). Retrieved 2024-11-19.
  22. ^ Haug, Alexander R.; Auernhammer, Christoph J.; Wängler, Björn; Schmidt, Gerwin P.; Uebleis, Christopher; Göke, Burkhard; Cumming, Paul; Bartenstein, Peter; Tiling, Reinhold; Hacker, Marcus (2010). "68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors". Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 51 (9): 1349–1356. doi:10.2967/jnumed.110.075002. ISSN 1535-5667. PMID 20720050.
  23. ^ Hartenbach, Markus; Hartenbach, Sabrina; Bechtloff, Winfried; Danz, Burkhardt; Kraft, Klaus; Klemenz, Burkhard; Sparwasser, Christoph; Hacker, Marcus (2014-06-15). "Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial". Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 20 (12): 3244–3253. doi:10.1158/1078-0432.CCR-13-2653. ISSN 1557-3265. PMID 24763613.
  24. ^ Graute, Vera; Jansen, Nathalie; Ubleis, Christopher; Seitz, Michael; Hartenbach, Markus; Scherr, Michael Karl; Thieme, Sven; Cumming, Paul; Klanke, Katharina; Tiling, Reinhold; Bartenstein, Peter; Hacker, Marcus (2012). "Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy". European Journal of Nuclear Medicine and Molecular Imaging. 39 (2): 271–282. doi:10.1007/s00259-011-1970-2. ISSN 1619-7089. PMID 22086143.
  25. ^ Nachrichten, Salzburger (2017-10-19). "Drei Österreicher sterben täglich am Prostatakarzinom". Salzburger Nachrichten (in German). Retrieved 2024-11-11.
Retrieved from "https://wiki.riteme.site/w/index.php?title=Marcus_Hacker&oldid=1260593816"